Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.3%
5Y CAGR+35.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+27.3%/yr
Annual compound
5Y CAGR
+35.1%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.5x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $71.52M | +28.1% |
| 2024 | $55.82M | +7.8% |
| 2023 | $51.78M | +49.6% |
| 2022 | $34.63M | +36.2% |
| 2021 | $25.42M | +60.1% |
| 2020 | $15.88M | +339.0% |
| 2019 | $3.62M | - |